Urolithin A vs Ellagic Acid: Why the Gut Metabolite Matters More
Key takeaways
- Ellagic acid is a precursor; urolithin A is the postbiotic your gut bacteria produce from it. They are not interchangeable.
- Dietary ellagic acid and ellagitannins are "difficult" for the gut to absorb, whereas urolithin A is readily absorbed and reaches micromolar levels in plasma.
- The conversion depends on your personal gut-microbiome makeup — researchers group people into metabotypes, and a meaningful share produce little or no urolithin A.
- In worm studies, urolithin A extended lifespan while ellagic acid did not — a direct hint that the metabolite, not the precursor, carries the mitophagy activity (preclinical).
- A standardized urolithin A supplement delivers the finished molecule directly, bypassing the converter lottery.
If you have read about pomegranate and "cellular renewal," you have probably run into two names that get used almost interchangeably: ellagic acid and urolithin A. They are closely related, but they are not the same thing — and the difference between them is one of the most important ideas in this entire category. One is what you eat. The other is what your body actually uses. This article walks through how they connect, why the gut conversion step is the bottleneck, and what that means for anyone deciding how to get urolithin A.
What is ellagic acid?
Ellagic acid is a polyphenol found in pomegranates, walnuts, raspberries, strawberries, and other plants. In whole foods it mostly exists bound up in larger molecules called ellagitannins. When you eat these foods, digestive conditions release free ellagic acid in the gut. It is a genuine antioxidant compound in the lab, which is why it has been studied for decades.
The catch is bioavailability. As one 2024 microbiology analysis put it, ellagitannins "have various health effects, but their absorption by the [gastrointestinal tract] is difficult" (Fang et al., Applied Microbiology and Biotechnology, 2024). Very little ellagic acid crosses into the bloodstream intact. Instead, most of it travels further down the gut, where resident bacteria get to work on it.
What is urolithin A?
Urolithin A is a postbiotic — a compound produced by gut bacteria from a dietary precursor. It is the downstream product of ellagic acid metabolism, and unlike its parent it is absorbed efficiently, appearing in plasma at micromolar concentrations (Fang et al., 2024). Urolithin A is the molecule researchers are actually interested in when they study pomegranate and cellular aging, because it is the form that reaches tissues.
Its best-characterized activity is as a mitophagy activator — it supports the cellular housekeeping process that clears out worn-out mitochondria so cells can maintain a healthier energy-producing pool. This was first mapped in model organisms (Ryu et al., Nature Medicine, 2016 — PRECLINICAL) and later examined in people, where oral urolithin A was found to be safe and to shift blood markers of mitochondrial and cellular health (Andreux et al., Nature Metabolism, 2019 — HUMAN).
How ellagic acid becomes urolithin A
The conversion is a multi-step microbial pathway. Gut bacteria strip chemical groups off ellagic acid in stages, producing a sequence of intermediate urolithins before arriving at urolithin A. In the words of the 2024 analysis, "Uro-A can only be derived from Uro-C, while Uro-M5 and Uro-M6 are direct precursors of Uro-C" (Fang et al., 2024). Specific bacteria drive these steps — genera such as Gordonibacter and Ellagibacter, along with certain Bifidobacterium strains, have been identified as urolithin producers. Notably, the exact enzymes and genes "are currently unknown."
Because the pathway depends on which microbes live in your gut, people differ in what they produce. Researchers describe three urolithin metabotypes (Tomás-Barberán et al., Molecular Nutrition & Food Research, 2017; García-Villalba et al., 2022):
| Metabotype | What the gut produces | Practical meaning |
|---|---|---|
| UM-A | Urolithin A as the end product | Converts ellagic acid efficiently into the active metabolite |
| UM-B | Urolithin A plus urolithin B / iso-urolithin A | Converts, but with a different mix of end products |
| UM-0 | Little to no urolithins | Eating the precursor yields minimal urolithin A |
Metabotype is not fixed for life — it can shift with diet, age, and gut-health changes — but at any given moment it sets a ceiling on how much urolithin A your own microbes can make from food.
Ellagic acid vs urolithin A at a glance
| Feature | Ellagic acid | Urolithin A |
|---|---|---|
| What it is | Plant polyphenol (precursor) | Gut-bacteria metabolite (postbiotic) |
| Found in | Pomegranate, walnuts, berries | Made in the body; not present in food in meaningful amounts |
| Absorption | Poor — little reaches the blood | Good — reaches micromolar plasma levels |
| Requires gut conversion? | Yes, to become active urolithins | No — already the finished molecule |
| Mitophagy activity (lab) | Did not extend lifespan in C. elegans | Extended lifespan ~45% in C. elegans (preclinical) |
Why the metabolite matters more
Two findings make the case that urolithin A — not ellagic acid — is the compound of interest. First, bioavailability: ellagic acid barely gets absorbed, so eating more of it does not reliably raise what your tissues receive. Second, and more striking, is a direct comparison in worms. When researchers tested the urolithins head-to-head, urolithin A extended mean lifespan by about 45%, while "ellagic acid had no effect" (Ryu et al., 2016 — PRECLINICAL). The biological signal tracked the metabolite, not the parent compound.
Human work has continued with urolithin A specifically. A randomized controlled trial in adults aged 65–90 found that four months of 1,000 mg daily urolithin A improved muscle endurance at the two-month mark and favorably shifted several plasma mitochondrial biomarkers, though its primary endpoints were not met and the authors called the endurance findings exploratory (Liu et al., JAMA Network Open, 2022 — HUMAN). A separate randomized trial in middle-aged adults reported changes in muscle and plasma markers of mitochondrial health (Singh et al., Cell Reports Medicine, 2022 — HUMAN). None of this research is run on ellagic acid as the active agent — it is run on urolithin A.
Should you focus on ellagic acid or urolithin A?
If your goal is simply a polyphenol-rich diet, foods high in ellagitannins are a worthwhile part of healthy eating for many reasons. But if the specific goal is to get urolithin A to your cells, relying on dietary ellagic acid runs into the converter problem: a UM-0 metabotype may turn very little of it into the active molecule. This is the logic behind supplementing with the finished compound. As a 2021 review summarized, direct urolithin A supplementation sidesteps the variability of individual gut metabolism (D'Amico et al., Trends in Molecular Medicine, 2021). A standardized urolithin A product — such as SOMA Urolithin A gummies — delivers a known dose of the metabolite itself, so the result does not hinge on your converter status.
This is a structure/function distinction about cellular housekeeping and mitochondrial support, not a treatment for any condition. If you take medications or have a health concern, talk with your healthcare provider before starting a new supplement.
Frequently asked questions
Is ellagic acid the same as urolithin A?
No. Ellagic acid is the dietary precursor; urolithin A is the metabolite your gut bacteria make from it. Urolithin A is the absorbed, biologically active form studied for mitophagy support.
Can I just eat pomegranate instead of taking urolithin A?
You can get ellagitannins and ellagic acid from pomegranate, but whether they become urolithin A depends on your gut microbes. People with a UM-0 metabotype produce little to none, which is why a direct supplement offers consistency.
Does ellagic acid have any benefits of its own?
Ellagic acid is an antioxidant in laboratory settings and is part of a polyphenol-rich diet. However, its poor absorption limits how much reaches the bloodstream intact, and the lifespan and mitophagy signals in research track urolithin A instead.
How do I know my metabotype?
There is no simple at-home test in routine use. Because metabotype varies and can change over time, many people choose a standardized urolithin A supplement rather than trying to estimate their own conversion.
Is urolithin A safe?
In human studies, oral urolithin A was well tolerated, including at 1,000 mg daily for four months, with no serious adverse events reported in the trials cited above. As always, check with your provider if you are pregnant, nursing, or on medication.
Support your cellular health, every day
SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.
Shop SOMA Urolithin A Gummies →These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.